3-Methyl-7-propylxanthine is primarily used in research and development within the pharmaceutical industry. It is studied for its potential therapeutic effects, particularly in the context of neurological and cardiovascular conditions. The compound has shown promise in modulating adenosine receptors, which play a critical role in regulating various physiological processes, including heart rate, blood flow, and neurotransmitter release. This makes it a candidate for developing drugs aimed at treating conditions such as hypertension, arrhythmias, and certain neurodegenerative disorders. Additionally, its stimulant properties are explored for potential applications in enhancing cognitive function or combating fatigue. Ongoing studies continue to investigate its efficacy and safety for these applications.